Introduction {#sec1-1}
============

After tooth extraction, the healing process initiates however, alveolar socket never reaches its previous dimensions either buccolingually or apicocoronally. \[[@ref1]\] Additionally, the remaining bone structure after healing undergoes a progressive resorption (catabolic remodeling). Resorption in the first 6 months after extraction is very fast; however, it slows down and mildly continues for the rest of the person's life. Successful replacement of lost teeth through conventional prosthodontic treatments or implant placement is challenging in an atrophic alveolar ridge. \[[@ref1]-[@ref2]\]Bone loss compromises the support, retention, stability, and esthetics of dental prosthetics along with the health of the remaining tissues. \[[@ref3]\]

Bone mass is regulated through the process of remodeling which includes two phases including bone formation by osteoblasts and bone resorption by osteoclasts. Besides, osteoblasts play a role in differentiation of osteoclasts. \[[@ref4]\] Recent investigations have demonstrated that central and peripheral nervous systems play a significant role in regulation of bone mass. \[[@ref5]\] Leptin stimulates the sympathetic nervous system \[[@ref6]-[@ref7]\] and this system intrinsically results in increased expression of RANKL (Receptor activator of nuclear factor kappa-B ligand) receptor on their surface by stimulating the β2-adrenergic receptors on the surface of osteoblasts. The interaction between RANKL and RANK (Receptor activator of nuclear factor kappa-B) on the surface of osteoclasts precursors, transforms them into osteoclasts. \[[@ref4],[@ref8]\]

Considering the above mentioned findings, various researchers have suggested the use of β2-adrenergic receptor antagonists in prevention or treatment of bone resorption. \[[@ref7]-[@ref18]\] Several reports discuss the decreased risk of fracture in those using propranolol which is a non-specific β2-adrenergic receptor antagonist. \[[@ref7]-[@ref18]\] Takeda *et al*. \[[@ref7]\] and Bonnet *et al*. \[[@ref19]\] demonstrated that a non-specific β2-adrenergic receptor antagonist like propranolol can enhance bone formation in female rats that had undergone ovariectomy.

If beta-blockers are truly capable of preventing bone resorption in humans, the above mentioned findings can be successfully implemented in oral cavity for extraction socket healing or prevention of progressive alveolar bone resorption following teeth loss. Therefore, the present study was conducted to evaluate the effect of β2-adrenergic receptor antagonists on number of osteoblasts and osteoclasts in alveolar socket following tooth extraction in animal models.

Materials and Method {#sec1-2}
====================

A total of 40, eight-week old Wistar rats with a mean weight of 270±50 g were selected from an inbred colony. During the study period, the rats were divided into 10 groups of 4 each and kept in an standard cage in a room under controlled conditions with a temperature of 21±2°C and 50%±7% moisture in 12 hours dark and 12 hours light cycle and free access to standard food and water. The rats were brought to the lab one week before the initiation of study to make them acquainted to the environment. The samples were then randomly divided into 2 equal groups of test and control. Color coding system was used for identification of animals to blind the study.

It should be mentioned that the present study was conducted regarding the ethical guidelines of animal model studies designed by the Research Deputy of the Ministry of Health and was approved by the Ethics Committee of Animal Studies, Tabriz University of Medical Sciences.

Tooth extraction {#sec2-1}
----------------

Maxillary right first molars of rats in both test and control groups were extracted with an excavator (No.55, SMIC, China) under general anesthesia with IM ketamine hydrochloric acid 44 mg/kg (Rotexmedica, Germany). Hemostasis occurred approximately 5 minutes after tooth extraction and antibiotics or other medications were not administered.

Drug administration {#sec2-2}
-------------------

First, injectable propranolol (Tolidaroo, Iran), a non-specific beta-adrenergic receptor antagonist, was dissolved in sterile saline solution right before injection. It was then injected using an insulin syringe at a dosage of 0.1 mg/kg/day intraperitoneally during the whole study period and at a specific time (11.00 A.M) for all samples in the test group (n=20). The mentioned dosage has been proposed by Bonnet *et al*. \[[@ref19]\] as the lowest dosage capable of preventing bone loss without any cardiovascular effect. The same amount of saline solution was injected to the control group (n=20) with the same method. Injections continued in both groups until their sacrifice ([Figure 1](#JDS-18-37-g001.tif){ref-type="fig"}).

![The best protocol between control groups (group C) and test groups (group T).](JDS-18-37-g001){#JDS-18-37-g001.tif}

Histological evaluation of extraction socket {#sec2-3}
--------------------------------------------

At days 7, 14, 21 and 28 post-extraction, 5 samples of any of the case and control groups were randomly selected and sacrificed using diethyl ether (Pars Chemie, Iran). Maxillary bone was resected and immediately stored and fixed in 10% formalin for 48 hours. Then it was preserved in ethylene diamine tetra acetic (EDTA) 10% at 4°C and pH=7.2 for 21 days in order to become decalcified and embedded in paraffin. Tissue blocks were cut serially into 5-µm sections parallel to the sagittal plane using a microtome. We selected sections which contained tooth socket and its surrounding bone structure and were stained with Hematoxylin-Eosin. Osteoclasts and osteoblasts were counted twice by one blinded researcher at 4 random areas in the alveolar socket wall.

Statistical analysis {#sec2-4}
--------------------

Collected data were analyzed using SPSS version 13 software and included descriptive statistics (mean and standard deviation), unpaired t-test and one-way ANOVA using Fisher's protected least significant difference method. *p*\< 0.05 was considered statistically significant.

Results {#sec1-3}
=======

In the first week following tooth extraction, number of osteoclasts in the control group was significantly higher than the test group receiving propranolol ([Table 1](#T1){ref-type="table"} and [Figure 2a and 2b](#JDS-18-37-g002.tif){ref-type="fig"}).

###### 

Mean and standard deviation (SD) of osteoblasts (ob) and osteoclasts (oc) in the control (C) and test (T) groups at weeks 1 to 4 post-extraction

         Week 1 Mean (SD)                                Week 2 Mean (SD)   Week 3 Mean (SD)                                Week 4 Mean (SD)
  ------ ----------------------------------------------- ------------------ ----------------------------------------------- ------------------
  C-ob   6.35 (3.685)                                    18.80 (7.88)       16.80 (7.10)[\*](#t1f1){ref-type="table-fn"}    13.50 (3.23)
  T-ob   10.55 (2.906)                                   23.80 (3.56)       30.00 (9.354)[\*](#t1f1){ref-type="table-fn"}   20.50 (7.53)
  C-oc   12.95 (2.858)[\*](#t1f1){ref-type="table-fn"}   1.00 (1.62)        2.30 (1.57)[\*](#t1f1){ref-type="table-fn"}     1.35 (1.57)
  T-oc   4.85 (3.29)[\*](#t1f1){ref-type="table-fn"}     0.00               0.00[\*](#t1f1){ref-type="table-fn"}            0.40 (0.65)

p≤ 0.05

In the control group, accumulation of osteoclasts was observed not only in the interdental septum but also on the socket floor ([Figure 2a and 2b](#JDS-18-37-g002.tif){ref-type="fig"}). Also, a significant increase in number of osteoclasts in both groups was observed in the first week compared to the following weeks (*p*\< 0.05) ([Figure 3a and 3b](#JDS-18-37-g003.tif){ref-type="fig"} and [Figure 4a and 4b](#JDS-18-37-g004.tif){ref-type="fig"}).

![**a:** Accumulation of osteoclasts on the socket wall in the control group. **b:** Socket wall in the test group at week one following tooth extraction (10X magnification).](JDS-18-37-g002){#JDS-18-37-g002.tif}

![**a:** Comparison of the number of osteoclasts in the test group (T-oc) during the 4 weeks. **b:** Comparison of the number of osteoclasts in the control group (C-oc) during the 4 weeks.](JDS-18-37-g003){#JDS-18-37-g003.tif}

![**a:** Accumulation of osteoclasts in the socket in the control group. **b:** Accumulation of osteoblasts in the socket in the test group at week 3 post-extraction (40X magnification).](JDS-18-37-g004){#JDS-18-37-g004.tif}

The number of osteoblasts in the control group reached its maximum rate in the second week and remained constant in the 3^rd^ and 4^th^ weeks. The number of osteoblasts in the test group receiving propranolol increased similar to the control group but reached its maximum rate at week 3 and demonstrated a significant increase compared to the control group (*p*\< 0.05) ([Figure 4a and 4b](#JDS-18-37-g004.tif){ref-type="fig"} and [Figure 5a and 5b](#JDS-18-37-g005.tif){ref-type="fig"}). However, a significant reduction in osteoblast number was observed in week 4 ([Figure 5a and 5b](#JDS-18-37-g005.tif){ref-type="fig"}). [Figure 6](#JDS-18-37-g006.tif){ref-type="fig"} demonstrates the difference in trabecular thickness and number and also the width of bone marrow space in the bone covering alveolar socket floor in test and control rats.

![**a:** Comparison of the number of osteoblasts in the test group (T-ob) during the 4 weeks. **b:** Comparison of the number of osteoblasts in the control group (C-ob) during the 4 weeks.](JDS-18-37-g005){#JDS-18-37-g005.tif}

![**a:** New bone formation in tooth socket in the control group. **b:** New bone formation in tooth socket in the test group at week 4 following the tooth extraction (10X magnification).](JDS-18-37-g006){#JDS-18-37-g006.tif}

Discussion {#sec1-4}
==========

In the present experimental study, we found that β2 adrenergic receptor antagonists could decrease the number of osteoclast and increase the number of osteoblast during extraction socket healing.

Our study results revealed that in the first week following tooth extraction, when bone resorption is the dominant process, a significant increase was detected in the number of osteoclasts in both groups compared to the following weeks and the number of osteoclasts in the control group was significantly higher than the test group receiving propranolol (*p*\< 0.05).

The mechanism of action of beta-blockers in regulating bone mass is through the stimulation of osteogenesis and decreasing bone resorption by preventing the differentiation of osteoclasts through RANK-RANKL system.\[[@ref7]-[@ref19]\] Since beta-blockers are widely used for treatment of cardiovascular diseases,\[[@ref13]\] epidemiologic studies in this respect are feasible. Studies have demonstrated that use of beta-blockers has been associated with lower risk of fractures. Considering the association of sympathetic nervous system with bone metabolism, medical researchers have seriously focused on the application of beta-blockers for prevention and treatment of osteoporosis.\[[@ref9]-[@ref18]\]

In dentistry, the relationship between beta-blockers and bone loss has been the focus of attention for some time now. Kim *et al*.\[[@ref20]\] induced alveolar bone loss by superior cervical ganglionectomy and oral challenge with *P. gingivalis*.

We found that the number of osteoclasts in the control group was significantly higher than the test group receiving propranalol which our results are in agreement of Okada et al. \[[@ref21]\] study. They assessed the effects of a beta-blocker on alveolar bone loss induced by *P. gingivalis* infection in rats to examine the involvement of sympathetic nervous system in periodontal breakdown and indicated that beta-blockers inhibited osteoclast differentiation and prevented alveolar bone loss by controlling the alveolar bone mass metabolism. Shimizu *et al*. \[[@ref22]\] also demonstrated that sympathetic nervous activity can affect bone loss induced by occlusal hypo-function in rats.

Decreased number of osteoclasts following beta-blocker administration that has been reported by other researchers as well \[[@ref20]-[@ref21]\] is indicative of the role of sympathetic nervous system in regulating bone mass and confirms the hypothesis of beta-blocker use for prevention of alveolar bone resorption following tooth extraction.

The number of osteoblasts reached its maximum rate in week 2 in the control and in week 3 in the pro- pranolol group and showed a significant increase in the test group compared to the control group. Number of osteoblasts decreased afterwards and osteoclasts reappeared. The above mentioned findings are in accord with animal model studies on extraction socket healing in rats indicating that osteogenesis initiated in the middle of the 2^nd^ week post-extraction and slowed down at the end of the 3^rd^ week when the tooth socket is mostly filled with newly formed bone. \[[@ref23]-[@ref24]\] However, in rats receiving propranolol although the number of osteoblasts at week 2 increased similar to the control group, in contrast to the controls, this increase continued until week 3 and number of osteoblasts revealed a significant difference with that of the controls ([Figure 4](#JDS-18-37-g004.tif){ref-type="fig"}). In fact, duration of osteogenesis phase in the propranolol group was longer than that in the control group which is in agreement with other studies reporting increased osteogenesis in rats receiving propranolol. \[[@ref7]-[@ref19]\] Our results clearly demonstrate the difference in trabecular number and thickness and also the width of bone marrow space in the bone covering alveolar socket floor in test and control rats.

The present study results need to be confirmed by further laboratory and clinical studies. Investigation of bone density in the repaired socket is suggested for further studies. However, considering our obtained results, a hypothesis can be proposed regarding the prevention of alveolar bone resorption following tooth extraction by using beta-blockers.

Conclusion {#sec1-5}
==========

In a conclusion, β2 adrenergic receptor antagonists decrease the number of osteoclasts and increase the number of osteoblasts during extraction socket healing.
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